Determining the concentration of microorganisms controlled by attributes sampling plans

Autor: Martin B. Cole, Susanne Dahms, J. David Legan, Mark H. Vandeven

Publikováno v: Food Control. 12:137-147

We present a method of translating the performance of attributes sampling plans, such as those recommended by the International Commission on Microbiological Specifications for Foods (ICMSF), so that the user can estimate the concentration of organis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2cc2b4eb6d7251bd2f46464cee78c869
https://doi.org/10.1016/s0956-7135(00)00033-5

Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b

Autor: Chris, Polman, Ludwig, Kappos, Mark S, Freedman, Gilles, Edan, Hans-Peter, Hartung, David H, Miller, Xavier, Montalbán, Frederick, Barkhof, Krzysztof, Selmaj, Bernard M J, Uitdehaag, Susanne, Dahms, Lars, Bauer, Christoph, Pohl, Rupert, Sandbrink, S, Howell

Publikováno v: Journal of neurology, Vol. 255, no.4, p. 480-7 (2008)
Journal of Neurology, 255(4), 480-487. D. Steinkopff-Verlag
Polman, C, Kappos, L, Freedman, M, Edan, G, Hartung, H P, Miller, D H, Montalbán, X, Barkhof, F, Selmaj, K, Uitdehaag, B, Dahms, S, Bauer, L, Pohl, C & Sandbrink, R 2007, ' Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b ', Journal of Neurology .
Journal of Neurology. D. Steinkopff-Verlag
Polman, C H, Kappos, L, Freedman, M S, Edan, G, Hartung, H P, Miller, D H, Montalban, X, Barkhof, F, Selmaj, K, Uitdehaag, B M J, Dahms, S, Bauer, L, Pohl, C & Sandbrink, R 2008, ' Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b ', Journal of Neurology, vol. 255, no. 4, pp. 480-487 . https://doi.org/10.1007/s00415-007-0733-2

BACKGROUND : The BENEFIT study examined interferon beta (IFNB)-1b treatment in patients with clinically isolated syndrome (CIS) and > or = 2 clinically silent brain MRI lesions. METHODS : Subgroups of 468 patients (IFNB-1b: n = 292; placebo: n = 176)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e80cda843df17a9d368fc9d69af95b42
https://pubmed.ncbi.nlm.nih.gov/18004635

[Dose-response-models and their implications for quantitative risk assessment for Campylobacter infections]

Autor: Elke, Stellbrink, Susanne, Dahms

Publikováno v: Berliner und Munchener tierarztliche Wochenschrift. 117(5-6)

For some time now there have been several projects dealing with the assessment of campylobacteriosis risks for consumers. Dose-response relationships form a crucial part of such assessments, as they specify disease probabilities depending on differen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::30b49c2abf766127b6bf2fa2f1961905
https://pubmed.ncbi.nlm.nih.gov/15188680

[Epidemiological model development using BSE as an example--observations from a statistical viewpoint]

Autor: Susanne, Dahms

Publikováno v: Berliner und Munchener tierarztliche Wochenschrift. 116(1-2)

Since first BSE cases in cattle born in Germany were recognized, questions have been raised concerning the future development of the disease and the epidemiological dynamics of BSE, and, consequently, modelling approaches that might answer these ques

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::72f382ac84d2cd265af2d591983ad5f1
https://pubmed.ncbi.nlm.nih.gov/12592925

FrontMatter.

Publikováno v: Handbook of Epidemiology; 2014, pi-xxx, 30p